Jingfang Pharmaceutical-B (02595) transferred 43.7371 million shares from Standard Chartered Bank (Hong Kong) with a total market value of HK$1,125 million, accounting for 12.80%

The Zhitong Finance App learned that the latest data from the Hong Kong Stock Exchange shows that on September 18, Jinfang Pharmaceutical-B (02595) changed positions, with a total transfer market value of HK$1,125 billion, accounting for 12.80%. The company's shareholders transferred 444.487 million shares to Goldman Sachs (Asia) Securities and 43.771 million shares from Standard Chartered Bank (Hong Kong).

Jingfang Pharmaceutical announced that on September 18, 2026, the company spent HK$8.119 million to repurchase 319,000 shares.